NEXTBio Capital Management LP
CIK 0002038158 · AUSTIN, TX · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$217.4M
2026 Q2
Positions
22
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
77.7%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
PTGX
PROTAGONIST THERAPEUTICS INC
12.4%
STTK
SHATTUCK LABS INC
11.9%
CMPS
COMPASS PATHWAYS PLC
11.6%
GPCR
STRUCTURE THERAPEUTICS INC
7.7%
VOR
VOR BIOPHARMA INC
7.5%
RYTM
RHYTHM PHARMACEUTICALS INC
6.7%
PVLA
PALVELLA THERAPEUTICS INC NE
6.3%
XENE
XENON PHARMACEUTICALS INC
5.1%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.